Search
for
Sort by
Research 481–510 of 644
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 2 approved]
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 1 approved]
- Antiandrogenic therapy with ciproterone acetate in female patients who suffer from both androgenetic alopecia and acne vulgaris
- Principles of chemotherapy
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
- Therapeutic and Clinical Potential of Adipose-Derived Stem Cell Secretome for Skin Regeneration
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP)
- The JAK/STAT signaling pathway: from bench to clinic
- Pathological sequelae of long-haul COVID
- Vaccines, adjuvants and autoimmunity
- Late-Onset Systemic Lupus Erythematosus
- Chemical Composition and Biological Activities of Essential Oils of Curcuma Species
- Tissue engineering; strategies, tissues, and biomaterials
- Progestogens with Antiandrogenic Properties
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Androgen insufficiency in women: diagnostic and therapeutic implications
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Engineered extracellular vesicles for tissue repair and regeneration
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant products
- A Comprehensive Review of Acne Vulgaris
- Epidemiology of Cosmetic Procedures: An Update for Dermatologists
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19